Mike McDermott, chief global supply officer and executive vice-president at the pharmaceutical giant, said the company had a very strong development pipeline for new products, which needed flexible facilities.
“Our pipeline is incredibly strong, and we need facilities that can accept that pipeline and are nimble ...